Company news
Lyell Immunopharma, Inc. news in 2021
Lyell Immunopharma, Inc.'s news releases, calls and decks from 2021, newest first.
Lyell Immunopharma Announces FDA Clearance of its IND for LYL797, a CAR T-Cell Therapy Incorporating Novel Reprogramming Technologies for Solid Tumors
December 15, 2021
Lyell Immunopharma Announces cGMP Qualification of LyFE™ Manufacturing Center in Advance of Initiating Clinical Programs
December 14, 2021
Lyell Immunopharma Announces Return of Dr. Rick Klausner as Board Chair
December 1, 2021
Lyell Immunopharma Reports Third Quarter 2021 Financial Results and Business Highlights
November 11, 2021
Lyell Immunopharma Reports Second Quarter 2021 Financial Results and Business Highlights
August 11, 2021
Lyell Immunopharma Announces Pricing of Initial Public Offering
June 15, 2021